0001104659-16-094719.txt : 20160310 0001104659-16-094719.hdr.sgml : 20160310 20160208171934 ACCESSION NUMBER: 0001104659-16-094719 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20160208 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AveXis, Inc. CENTRAL INDEX KEY: 0001652923 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 901038273 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 2275 HALF DAY ROAD STREET 2: SUITE 160 CITY: BANNOCKBURN STATE: IL ZIP: 60015 BUSINESS PHONE: 972-725-7797 MAIL ADDRESS: STREET 1: 2275 HALF DAY ROAD STREET 2: SUITE 160 CITY: BANNOCKBURN STATE: IL ZIP: 60015 CORRESP 1 filename1.htm

 

Goldman, Sachs & Co.

200 West Street

New York, NY 10282

 

Jefferies LLC

520 Madison Avenue

New York, NY 10022

 

February 8, 2016

 

VIA EDGAR

 

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C.  20549

Attention: Tara Keating Brooks

 

Re:                             AVEXIS, INC.

Registration Statement on Form S-1 (File No. 333-209019)

 

Ladies and Gentlemen:

 

Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), we hereby join AveXis, Inc. (the “Company”) in requesting that the effective date for the registration statement referred to above be accelerated so that it will be declared effective at 4:00 p.m. Eastern Time on February 10, 2016 or as soon as possible thereafter.

 

In connection with this acceleration request and pursuant to Rule 460 under the Act, we wish to advise you that we have effected the following distribution of the Company’s preliminary prospectus dated February 1, 2016 through the date hereof:

 

Preliminary Prospectus dated February 1, 2016

 

3,461 copies to prospective underwriters, institutional investors, dealers and others.

 

The undersigned further advise you that they have complied and will continue to comply with Rule 15c2-8 under the Securities Exchange Act of 1934, as amended, in connection with the above-described offering.

 

[Remainder of page intentionally left blank]

 


 

 

Very truly yours,

 

 

 

GOLDMAN, SACHS & CO.

 

JEFFERIES LLC

 

 

 

As Representative of the several Underwriters

 

 

 

 

 

GOLDMAN, SACHS & CO.

 

 

 

By:

/s/ Matt Leavitt

 

Name:

Matt Leavitt

 

Title:

Managing Director

 

 

 

 

 

 

 

JEFFERIES LLC

 

 

 

By:

/s/ Ashley Delp Walker

 

Name:

Ashley Delp Walker

 

Title:

Managing Director

 

[Signature Page to Acceleration Request]